Test time has arrived: the first person has been treated in a highly anticipated gene therapy trial that aims to coax aged ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

A Boston company treated its first patient with a therapy intended to allow aging optic nerve cells to behave as though they were young again. The experimental treatment by Life Biosciences will ...

Cardiovascular disease continues to lead as the primary cause of death across the globe, taking millions of lives every year. Damage caused by these diseases is particularly difficult to repair, since ...

In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the "recipe" for the transformation. Researchers at Lund University have now created ...

Researchers at Tianjin First Central Hospital took fat cells from the woman who had been living with Type 1 diabetes for over ...

Leuven, 11 March 2025 – Solid tumors often provide a challenging environment for the T cells of our immune system. By reprogramming the metabolism of T cells, scientists at the VIB-KU Leuven Center ...

Reprogram Biosciences, a preclinical oncology biotechnology company developing mRNA-based therapeutics to treat solid tumors, today announced the close of its seed financing. The close brings total ...

A participant in a landmark clinical trial has been given a cellular-reprogramming treatment that aims to rejuvenate damaged ...